Stock listing

Intellia Therapeutics, Inc. (0JBU) Stock Price, News, Filings & Events

Selected listing: 0JBU · LSE · USD · GB

This page tracks Intellia Therapeutics, Inc.'s 0JBU:LSE listing on LSE in USD for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 0JBU:LSE. 0JBU:LSE is the selected stock listing for investors researching Intellia Therapeutics, Inc.; the company-level investor brief is shared across the issuer while this page keeps ticker, exchange, currency, and canonical URL signals specific to 0JBU:LSE. Intellia Therapeutics, Inc. is a public biotechnology company listed on 6ix the American stock market. The company focuses on developing innovative gene-editing therapies. As of now, Intellia has a market capitalization of approximately $2. 19 billion.

website0JBU:LSEUSDGBSEO content: aiUpdated June 26, 2026/stock/lse-0jbu/intellia-therapeutics-inc/l-t0g0jp11l5
Intellia Therapeutics, Inc. logo
Ticker
0JBU:LSE
Asset type
Stock
Market cap
$2.33B
Sector
Health Technology
Industry
Biotechnology
Exchange
LSE
Currency
USD

Intellia Therapeutics, Inc. 0JBU:LSE stock context

This page tracks Intellia Therapeutics, Inc.'s 0JBU:LSE listing on LSE in USD for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 0JBU:LSE. 0JBU:LSE is the selected stock listing for investors researching Intellia Therapeutics, Inc.; the company-level investor brief is shared across the issuer while this page keeps ticker, exchange, currency, and canonical URL signals specific to 0JBU:LSE. Intellia Therapeutics, Inc. is a public biotechnology company listed on 6ix the American stock market. The company focuses on developing innovative gene-editing therapies. As of now, Intellia has a market capitalization of approximately $2. 19 billion.

Research Intellia Therapeutics, Inc.

Alternate listings